JOHN JOSEPH LOONEY: Open Payments
NPI 1003848532 · MILTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,352 in 105 payments from 16 companies in 2025. Trend: 2023 $2,364 · 2024 $2,791 · 2025 $2,352
Food & beverage: $2,352
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $685 |
| AstraZeneca Pharmaceuticals LP | 11 | $297 |
| Lilly USA, LLC | 11 | $246 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $246 |
| Novo Nordisk Inc | 9 | $212 |
| Novartis Pharmaceuticals Corporation | 7 | $150 |
| PFIZER INC. | 7 | $147 |
| Exact Sciences Corporation | 3 | $69 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $61 |
| Otsuka America Pharmaceutical, Inc. | 3 | $59 |
Products named: JARDIANCE, AIRSUPRA, UBRELVY, Wegovy, CREON, LEQVIO, LINZESS, QULIPTA.
Industry payments across MA — which companies pay providers there.
